Resources

Type of publications
Regions
Diseases
4945 results found
2025 ∙ Harper, D. M. Navarro-Alonso, J. A. Bosch, F. X. Paavonen, J. Stanley, M. Sasieni, P. Yebenes, M. Martinez-Martinez, N. Rodriguez, A. Garcia, A. Martin-Gomez, L. Vallejo-Aparicio, L. Carrion, H. Ruiz Garcia, Y.
Impact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: A systematic literature review
Adolescents Adults Older adults Human papillomavirus (HPV) Efficacy/effectiveness Safety Administration
Rating:
Critically low
2025 ∙ Yitbarek, K. Mahimbo, A. Bobo, F. T. Woldie, M. Sheel, M. Frawley, J. Hayen, A.
Impact of measles vaccination strategies on vaccination rates in low-income and middle-income countries: a systematic review and meta-analysis
Children Newborn Low and Middle Income Countries Measles Coverage Efficacy/effectiveness Economic aspects
Rating:
Low
2025 ∙ Elghanam, Y. Kim, E. Y.
Impact of pharmacist intervention on enhancing vaccination coverage: A systematic review and meta-analysis
Adults Older adults Parents/caregivers Coverage
Rating:
Not applicable
2025 ∙ Amare, S. N. Yee, K. C. Leung, M. Naunton, M. Bushell, M.
Impact of pharmacist-led interventions on COVID-19, herpes zoster, influenza, pneumococcal, and respiratory syncytial virus vaccines uptake in people aged 60 years and older: Systematic review and meta-analysis
Adults Older adults Herpes zoster Influenza Pneumococcal disease RSV (Respiratory syncytial virus) COVID-19 Coverage
Rating:
Not applicable
2025 ∙ Pan, B. Y. Tseng, I. S. Feng, Y. C. Fang, C. T.
Impact of pre-Omicron COVID-19 vaccine boosters on the risk of Omicron variant infections: A systematic review and meta-regression
All age groups COVID-19 Efficacy/effectiveness Administration
Rating:
Low
2025 ∙ Saikia, K. Ahmed, R. Das, B. Paul, S. Ray, S. K. Chandra Deka, R. Borah, P. P. Saharia, N. Namsa, N. D.
Impact of Rotavac Vaccine on Hospital-Based Disease Prevalence and Strain Diversity in India: A Systematic Review and Meta-Analysis
South-East Asia India Newborn Children Rotavirus Efficacy/effectiveness
Rating:
Low
2025 ∙ Wang, C. Peng, L. Huang, X. Tsang, T. K.
Impact of Vaccination and Public Health Measures on the Severity of SARS-CoV-2 Omicron Infections in China: A Systematic Review and Meta-Regression Analysis
Western Pacific China All age groups COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Ong, D. S. Harris, M. Hart, J. D. Russell, F. M.
Indirect Effects of Universal Infant Rotavirus Vaccination: A Narrative Systematic Review
All age groups Low and Middle Income Countries Rotavirus Efficacy/effectiveness
Rating:
Moderate
2025 ∙ Yang, W. K. Shao, S. C. Liu, C. C. Chi, C. C.
Influenza vaccination and risk of dementia: a systematic review and meta-analysis
All age groups Influenza Efficacy/effectiveness Administration
Rating:
Low
2025 ∙ Thomas, R. E. Jefferson, T. Lasserson, T. J. Earnshaw, S.
Influenza vaccination for healthcare workers who care for people aged 60 or older living in long‐term care institutions
Healthcare workers Influenza Efficacy/effectiveness
Rating:
High
Loading...